|
1
|
GBD 2019 Dementia Forecasting
Collaborators. Estimation of the global prevalence of dementia in
2019 and forecasted prevalence in 2050: An analysis for the global
burden of disease study 2019. Lancet Public Health. 7:e105–e125.
2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Pyne JD and Brickman AM: The impact of the
COVID-19 pandemic on dementia risk: Potential pathways to cognitive
decline. Neurodegener Dis. 21:1–23. 2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Han Y, Yuan K, Wang Z, Liu WJ, Lu ZA, Liu
L, Shi L, Yan W, Yuan JL, Li JL, et al: Neuropsychiatric
manifestations of COVID-19, potential neurotropic mechanisms, and
therapeutic interventions. Transl Psychiatry.
11(499)2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Steardo L Jr, Steardo L and Verkhratsky A:
Psychiatric face of COVID-19. Transl Psychiatry.
10(261)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Grolli RE, Mingoti MED, Bertollo AG,
Luzardo AR, Quevedo J, Réus GZ and Ignácio ZM: Impact of COVID-19
in the mental health in elderly: Psychological and biological
updates. Molecular Neurobiology. 58:1905–1916. 2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zhang S, Yang Z, Li ZN, Chen ZL, Yue SJ,
Fu RJ, Xu DO, Zhang S and Tang YP: Are older people really more
susceptible to SARS-CoV-2? Aging Dis. 2022.
|
|
7
|
da Rosa Mesquita R, Francelino Silva
Junior LC, Santos Santana FM, Farias de Oliveira T, Campos
Alcântara R, Monteiro Arnozo G, Rodrigues da Silva Filho E, Galdino
Dos Santos AG, Oliveira da Cunha EJ, Salgueiro de Aquino SH and
Freire de Souza CD: Clinical manifestations of COVID-19 in the
general population: Systematic review. Wien Klin Wochenschr.
133:377–382. 2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Davis HE, Assaf GS, McCorkell L, Wei H,
Low RJ, Re'em Y, Redfield S, Austin JP and Akrami A: Characterizing
long COVID in an international cohort: 7 Months of symptoms and
their impact. EClinicalMedicine. 38(101019)2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Tatu AL, Nadasdy T and Bujoreanu FC:
Familial clustering of COVID-19 skin manifestations. Dermatol Ther.
33(e14181)2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Tatu AL, Nadasdy T and Nwabudike LC:
Observations about sexual and other routes of SARS-CoV-2 (COVID-19)
transmission and its prevention. Clin Exp Dermatol. 45:761–762.
2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Spudich S and Nath A: Nervous system
consequences of COVID-19. Science. 375:267–269. 2022.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Thye AY, Law JW, Tan LT, Pusparajah P, Ser
HL, Thurairajasingam S, Letchumanan V and Lee LH: Psychological
symptoms in COVID-19 patients: Insights into pathophysiology and
risk factors of long COVID-19. Biology (Basel).
11(61)2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Frontera JA, Boutajangout A, Masurkar AV,
Betensky RA, Ge Y, Vedvyas A, Debure L, Moreira A, Lewis A, Huang
J, et al: Comparison of serum neurodegenerative biomarkers among
hospitalized COVID-19 patients versus non-COVID subjects with
normal cognition, mild cognitive impairment, or Alzheimer's
dementia. Alzheimer's Dement. 18:899–910. 2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Iodice F, Cassano V and Rossini PM: Direct
and indirect neurological, cognitive, and behavioral effects of
COVID-19 on the healthy elderly, mild-cognitive-impairment, and
Alzheimer's disease populations. Neurol Sci. 42:455–465.
2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Meier IB, Vieira Ligo Teixeira C, Tarnanas
I, Mirza F and Rajendran L: Neurological and mental health
consequences of COVID-19: Potential implications for well-being and
labour force. Brain Commun. 3(fcab012)2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Giunta S: Is inflammaging an
auto[innate]immunity subclinical syndrome? Immun Ageing.
3(12)2006.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Candore G, Colonna-Romano G, Balistreri
CR, Di Carlo D, Grimaldi MP, Listì F, Nuzzo D, Vasto S, Lio D and
Caruso C: Biology of longevity: Role of the innate immune system.
Rejuvenation Res. 9:143–148. 2006.PubMed/NCBI View Article : Google Scholar
|
|
18
|
World Health Organization (WHO): The
ICD-10 classification of mental and behavioural disorders:
Diagnostic criteria for research. WHO, Geneva, 1993. https://www.who.int/standards/classifications/classification-of-diseases.
Accessed May 25, 2022.
|
|
19
|
Tombaugh TN, McDowell I, Kristjansson B
and Hubley AM: Mini-mental state examination (MMSE) and the
modified MMSE (3MS): A psychometric comparison and normative data.
Psychol Assess. 8:48–59. 1996.
|
|
20
|
Shulman KI: Clock-drawing: Is it the ideal
cognitive screening test? Int J Geriatr Psychiatry. 15:548–561.
2000.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Nasreddine ZS, Phillips NA, Bédirian V,
Charbonneau S, Whitehead V, Collin I, Cummings JL and Chertkow H:
The montreal cognitive assessment, MoCA: A brief screening tool for
mild cognitive impairment. J Am Geriatr Soc. 53:695–699.
2005.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ciaccio M, Lo Sasso B, Scazzone C, Gambino
CM, Ciaccio AM, Bivona G, Piccoli T, Giglio RV and Agnello L:
COVID-19 and Alzheimer's disease. Brain Sci. 11(305)2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Frontera JA, Sabadia S, Lalchan R, Fang T,
Flusty B, Millar-Vernetti P, Snyder T, Berger S, Yang D, Granger A,
et al: A prospective study of neurologic disorders in hospitalized
patients with COVID-19 in New York City. Neurology. 96:e575–e586.
2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Virhammar J, Nääs A, Fällmar D, Cunningham
JL, Klang A, Ashton NJ, Jackmann S, Westman G, Frithiof R, Blennow
K, et al: Biomarkers for central nervous system injury in
cerebrospinal fluid are elevated in COVID-19 and associated with
neurological symptoms and disease severity. Eur J Neurol.
28:3324–3331. 2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Mongelli A, Barbi V, Gottardi Zamperla M,
Atlante S, Forleo L, Nesta M, Massetti M, Pontecorvi A, Nanni S,
Farsetti A, et al: Evidence for biological age acceleration and
telomere shortening in COVID-19 survivors. Int J Mol Sci.
22(6151)2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Mukaetova-Ladinska EB and Kronenberg G:
Psychological and neuropsychiatric implications of COVID-19. Eur
Arch Psychiatry Clin Neurosci. 271:235–248. 2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Livingston G, Huntley J, Sommerlad A, Ames
D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J,
Cooper C, et al: Dementia prevention, intervention, and care: 2020
Report of the lancet commission. Lancet. 396:413–446.
2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Rogers JP, Chesney E, Oliver D, Pollak TA,
McGuire P, Fusar-Poli P, Zandi MS, Lewis G and David AS:
Psychiatric and neuropsychiatric presentations associated with
severe coronavirus infections: A systematic review and
meta-analysis with comparison to the COVID-19 pandemic. Lancet
Psychiatry. 7:611–627. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
de Sousa GM, Tavares VDO, de Meiroz Grilo
MLP, Coelho MLG, de Lima-Araújo GL, Schuch FB and Galvão-Coelho NL:
Mental health in COVID-19 pandemic: A meta-review of prevalence
meta-analyses. Front Psychol. 12(703838)2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
He Y, Yu R and Ren J: The correlation
between psychiatric disorders and COVID-19: A narrative review.
Psychiatr Danub. 33:76–85. 2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Lega I, Nisticò L, Palmieri L, Caroppo E,
Lo Noce C, Donfrancesco C, Vanacore N, Scattoni ML, Picardi A,
Gigantesco A, et al: Psychiatric disorders among hospitalized
patients deceased with COVID-19 in Italy. EClinicalMedicine.
35(100854)2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Hawkins M, Sockalingam S, Bonato S,
Rajaratnam T, Ravindran M, Gosse P and Sheehan KA: A rapid review
of the pathoetiology, presentation, and management of delirium in
adults with COVID-19. J Psychosom Res. 141(110350)2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Taquet M, Geddes JR, Husain M, Luciano S
and Harrison PJ: 6-Month neurological and psychiatric outcomes in
236 379 survivors of COVID-19: A retrospective cohort study using
electronic health records. Lancet Psychiatry. 8:416–427.
2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Nakamura ZM, Nash RP, Laughon SL and
Rosenstein DL: Neuropsychiatric complications of COVID-19. Curr
Psychiatry Rep. 23(25)2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Nie XD, Wang Q, Wang MN, Zhao S, Liu L,
Zhu YL and Chen H: Anxiety and depression and its correlates in
patients with coronavirus disease 2019 in Wuhan. Int J Psychiatry
Clin Pract. 25:109–114. 2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Nalbandian A, Sehgal K, Gupta A, Madhavan
MV, McGroder C, Stevens JS, Cook JR, Nordvig AS, Shalev D, Sehrawat
TS, et al: Post-acute COVID-19 syndrome. Nat Med. 27:601–615.
2021.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Taquet M, Luciano S, Geddes JR and
Harrison PJ: Bidirectional associations between COVID-19 and
psychiatric disorder: Retrospective cohort studies of 62 354
COVID-19 cases in the USA. Lancet Psychiatry. 8:130–140.
2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Jones KA and Thomsen C: The role of the
innate immune system in psychiatric disorders. Mol Cell Neurosci.
53:52–62. 2013.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Miller AH and Raison CL: The role of
inflammation in depression: From evolutionary imperative to modern
treatment target. Nat Rev Immunol. 16:22–34. 2016.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Coperchini F, Chiovato L, Croce L, Magri F
and Rotondi M: The cytokine storm in COVID-19: An overview of the
involvement of the chemokine/chemokine-receptor system. Cytokine
Growth Factor Rev. 53:25–32. 2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Enache D, Pariante CM and Mondelli V:
Markers of central inflammation in major depressive disorder: A
systematic review and meta-analysis of studies examining
cerebrospinal fluid, positron emission tomography and post-mortem
brain tissue. Brain Behav Immun. 81:24–40. 2019.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Eyre HA, Air T, Pradhan A, Johnston J,
Lavretsky H, Stuart MJ and Baune BT: A meta-analysis of chemokines
in major depression. Prog Neuropsychopharmacol Biol Psychiatry.
68:1–8. 2016.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Yuan N, Chen Y, Xia Y, Dai J and Liu C:
Inflammation-related biomarkers in major psychiatric disorders: A
cross-disorder assessment of reproducibility and specificity in 43
meta-analyses. Transl Psychiatry. 9(233)2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Xia X, Wang Y and Zheng J: COVID-19 and
Alzheimer's disease: How one crisis worsens the other. Transl
Neurodegener. 10(15)2021.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Liu YH, Chen Y, Wang QH, Wang LR, Jiang L,
Yang Y, Chen X, Li Y, Cen Y, Xu C, et al: One-year trajectory of
cognitive changes in older survivors of COVID-19 in Wuhan, China: A
longitudinal cohort study. JAMA Neurol. 8:509–517. 2022.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Urazan JC, Padilla NE, Borda MG, Pinilla
J, Fernandez MAG Sr and Fan MV: Latin American older people and
neuropsychiatric symptoms: A mini-systematic review of effects of
COVID-19 pandemic. Alzheimers Dement. 17 (Suppl
12)(e058652)2021.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Hampshire A, Trender W, Chamberlain SR,
Jolly AE, Grant JE, Patrick F, Mazibuko N, Williams SC, Barnby JM,
Hellyer P and Mehta MA: Cognitive deficits in people who have
recovered from COVID-19. EClinicalMedicine.
39(101044)2021.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Xie Q, Liu XB, Xu YM and Zhong BL:
Understanding the psychiatric symptoms of COVID-19: A meta-analysis
of studies assessing psychiatric symptoms in Chinese patients with
and survivors of COVID-19 and SARS by using the symptom
checklist-90-revised. Transl Psychiatry. 11(290)2021.PubMed/NCBI View Article : Google Scholar
|
|
49
|
World Medical Association (WMA): WMA
Declaration of Helsinki-Ethical Principles for Medical Research
Involving Human Subjects. 7th revision. WMA, Ferney-Voltaire, 2013.
https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/.
Accessed February 20, 2022.
|
